1 Min Read
June 14 (Reuters) - Cellect Biotechnology Ltd
* Following the US, Cellect receives Russian patent covering any device and method using cellect’s flagship technology - the Apograft™ Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.